α-chloropropionaldehyde trimer | 142817-71-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三氧烷
• 英文名称: α-chloropropionaldehyde trimer
• 英文别名: 2,4,6-tris(1-chloroethyl)-1,3,5-trioxane
• CAS: 142817-71-8
• 化学式: C₉H₁₅Cl₃O₃
• mdl: MFCD01632187
• 分子量: 277.575
• InChiKey: XTQUGQZRFTWKFM-UHFFFAOYSA-N

物化性质

• 熔点：
  96°C

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  27.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  α-chloropropionaldehyde trimer 在 Montmorillonite K₁₀ 作用下， 反应 0.5h， 生成 2-氯丙醛
  参考文献：
  名称：

  One-pot Preparation of 2-Chloromethyldioxolanes and 2-Aminothiazoles from Chloromethyltrioxanes

  摘要：

  在蒙脱石粘土的催化剂量存在下，氯甲基三氧烷的热降解生成了高纯度的α-氯醛，这些产物分别与乙二醇或硫脲在原位处理后，分别得到了2-氯甲基二氧戊环和2-氨基噻唑。所用的粘土催化剂通过过滤被去除。

  DOI：

  10.1246/cl.1994.2039

文献信息

• Stabilization of reactive aldehydes by complexation with methylaluminum bis(2,6-diphenylphenoxide) and their synthetic application
  作者：Keiji Maruoka、Arnel B. Concepcion、Noriaki Murase、Masataka Oishi、Naoki Hirayama、Hisashi Yamamoto

  DOI：10.1021/ja00063a013

  日期：1993.5

  Reactive aldehydes such as formaldehyde and α-chloro aldehydes can be successfully generated by treatment of readily available trioxane and α-chloro aldehyde trimers, respectively, with methylaluminum bis(2,6-diphenylphenoxide) (MAPH), and stabilized as their 1:1 coordination complexes with MAPH. The resulting CH 2 =O.MAPH complex reacts with a variety of olefins to furnish ene-reaction products with

  通过分别用甲基铝双（2,6-二苯酚）（MAPH）处理容易获得的三恶烷和 α-氯醛三聚体，可以成功地生成反应性醛，如甲醛和 α-氯醛，并以 1:1与 MAPH 的配位配合物。所得的 CH 2 =O.MAPH 复合物与多种烯烃反应，提供具有优异区域选择性和立体选择性的烯反应产物。此外，该配合物以及 α-氯醛-MAPH 配合物可分别用作气态甲醛和活性 α-氯醛的稳定来源，用于各种碳负离子（有机金属化合物、烯醇化物等）的亲核加成。
• CONDENSED BENZAMIDE COMPOUNDS AND INHIBITORS OF VANILLOID RECEPTOR SUBTYPE 1 (VR1) ACTIVITY
  申请人：Koga Yoshihisa

  公开号：US20060035882A1

  公开（公告）日：2006-02-16

  To provide a compound having an excellent inhibitory effect on vanilloid receptor subtype 1 (VR1) activity which is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, acute pain, chronic pain, neuropathic pain, rheumatoid arthritis pain, neuralgia, etc. and a pharmaceutical composition containing the compound. The object has been attained by a condensed benzamide compound represented by the following formula (the symbols in the formula have the same meanings defined in the specification) or its salt:

  提供一种对vanilloid受体亚型1（VR1）活性具有出色抑制作用的化合物，该化合物对于治疗与vanilloid受体亚型1（VR1）活性有关的疾病具有有效性，如疼痛、急性疼痛、慢性疼痛、神经病性疼痛、类风湿性关节炎疼痛、神经痛等，以及含有该化合物的药物组合物。该目标通过下面的式子所代表的缩合苯甲酰胺化合物（式子中的符号在说明书中定义了相同的含义）或其盐实现：
• FUSED BENZAMIDE COMPOUND AND VANILLOID RECEPTOR 1 (VR1) ACTIVITY INHIBITOR
  申请人：Japan Tobacco, Inc.

  公开号：EP1777225A1

  公开（公告）日：2007-04-25

  To provide a compound having an excellent inhibitory effect on vanilloid receptor subtype 1 (VR1) activity which is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, acute pain, chronic pain, neuropathic pain, rheumatoid arthritis pain, neuralgia, etc. and a pharmaceutical composition containing the compound. The object has been attained by a condensed benzamide compound represented by the following formula (the symbols in the formula have the same meanings defined in the specification) or its salt:

  提供一种对香草素受体亚型 1（VR1）活性具有优异抑制作用的化合物，该化合物可有效治疗与香草素受体亚型 1（VR1）活性有关的疾病，如疼痛、急性疼痛、慢性疼痛、神经病理性疼痛、类风湿性关节炎疼痛、神经痛等，以及含有该化合物的药物组合物。由下式（式中符号与说明书中定义的含义相同）代表的缩合苯甲酰胺化合物或其盐已达到上述目的：
• Condensed benzamide compounds as inhibitors of vanilloid receptor subtype 1 (VR1) activity
  申请人：Japan Tobacco, Inc.

  公开号：EP2314585A1

  公开（公告）日：2011-04-27

  To provide a compound having an excellent inhibitory effect on vanilloid receptor subtype 1 (VR1) activity which is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, acute pain, chronic pain, neuropathic pain, rheumatoid arthritis pain, neuralgia, etc. and a pharmaceutical composition containing the compound. The object has been attained by a condensed benzamide compound represented by the following formula (the symbols in the formula have the same meanings defined in the specification) or its salt:

  提供一种对香草素受体亚型 1（VR1）活性具有优异抑制作用的化合物，该化合物可有效治疗与香草素受体亚型 1（VR1）活性有关的疾病，如疼痛、急性疼痛、慢性疼痛、神经病理性疼痛、类风湿性关节炎疼痛、神经痛等，以及含有该化合物的药物组合物。由下式（式中符号与说明书中定义的含义相同）代表的缩合苯甲酰胺化合物或其盐已达到上述目的：
• Wakasugi Takashi, Miyakawa Tadashi, Suzuki Fukuichi, Itsuno Shinichi, Ito+, Chem. Lett, (1994) N 11, S 2039-2042
  作者：Wakasugi Takashi, Miyakawa Tadashi, Suzuki Fukuichi, Itsuno Shinichi, Ito+

  DOI：——

  日期：——

表征谱图